A multicenter pilot evaluation of the National Institutes of Health chronic graft-versus-host disease (cGVHD) therapeutic response measures: feasibility, interrater reliability, and minimum detectable change.

A multicenter pilot evaluation of the National Institutes of Health chronic graft-versus-host disease (cGVHD) therapeutic response measures: feasibility, interrater reliability, and minimum detectable change. Biol Blood Marrow Transplant. 2011 Nov; 17(11):1619-29.

View in: PubMed

subject areas

Adolescent
Adult
Aged
Child
Child, Preschool
Chronic Disease
Female
Graft vs Host Disease
Hematology
Humans
Leukemia
Lymphoma
Male
Middle Aged
Multiple Myeloma
National Institutes of Health (U.S.)
Pilot Projects
Prospective Studies
Stem Cell Transplantation
United States
Young Adult

authors with profiles

Michael R. Bishop